Carbocisteine
Pecto Drill contains the active substance carbocisteine, which affects the composition of bronchial secretions. Carbocisteine makes the secretions less viscous and more fluid, making them easier to remove from the airways during coughing (mucolytic action). This medication is used for the symptomatic treatment of respiratory system diseases characterized by excessive production of thick and viscous secretions. Pecto Drill is indicated for use in adults, adolescents, and children over 2 years of age.
Before starting to use Pecto Drill Syrup, you should discuss it with your doctor, as special caution is required when using Pecto Drill:
Tell your doctor or pharmacist about all medications you are currently taking or have recently taken, as well as any medications you plan to take. When using Pecto Drill Syrup, do not use other medications containing carbocisteine (to avoid exceeding the maximum dose), antitussive medications, or medications that reduce bronchial secretion.
The use of this medication is not recommended in pregnant women. The use of this medication is contraindicated during breastfeeding (see "When Not to Use Pecto Drill Syrup"). If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before using this medication.
Pecto Drill Syrup has no or negligible influence on the ability to drive and use machines.
This medication should always be used as directed by your doctor. If you are unsure, consult your doctor or pharmacist. 15 ml of syrup contains 750 mg of carbocisteine. A measuring cup is included with the packaging, allowing you to measure the correct volume of syrup. Dosage Adults and adolescents over 12 years old: The recommended dose is 15 ml of syrup, initially 3 times a day (3 x 15 ml). Fill the measuring cup to the 15 ml mark. After the mucolytic effect occurs (thinning of secretions), the dosage can be reduced to 10 ml of syrup 3 times a day (3 x 10 ml). Fill the measuring cup to the 10 ml mark. The maximum daily dose is 45 ml of syrup (3 x 15 ml). Children: from 6 to 12 years old: the recommended dose is 5 ml of syrup 3 times a day (fill the measuring cup to the 5 ml mark); from 2 to 5 years old: the recommended dose is 2.5 ml to 5 ml of syrup 2 times a day (fill the measuring cup to the 2.5 ml or 5 ml mark); under 2 years old: the syrup is contraindicated in children under 2 years old. It is recommended that the child drinks water after taking the dose. Do not use this medication before bedtime. Route and Method of Administration This medication is for oral use. Shake the bottle before use. Always wash the measuring cup with water and let it dry after use. Store the bottle and measuring cup together in the carton for the next use in a safe place out of the reach of children. Duration of Treatment The duration of treatment should be limited to five days. After this time, if symptoms do not resolve, consult your doctor. Do not exceed the recommended daily dose. After taking the syrup, do not suppress the cough reflex. This will help remove mucus and phlegm from the lungs. If you feel that the effect of the medication is too strong or too weak, consult your doctor or pharmacist.
In case of taking more than the recommended dose of Pecto Drill Syrup, stop taking the medication and immediately consult your doctor or pharmacist. Symptoms of overdose may include gastrointestinal disorders (including nausea, vomiting, diarrhea, and abdominal pain).
Take the missed dose as soon as possible, unless it is time for the next dose. In this case, skip the missed dose and continue using the medication as usual. Do not take a double dose to make up for the missed dose. If you have any further questions about using this medication, consult your doctor or pharmacist.
Like all medications, Pecto Drill Syrup can cause side effects, although not everybody gets them. The following side effects may occur with an unknown frequency (cannot be estimated from the available data):
If you experience any of these symptoms, consult your doctor, who will recommend reducing the dose or stopping the medication.
If you experience any side effects, including any not listed in this leaflet, inform your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website: https://smz.ezdrowie.gov.pl Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medication.
Keep the medication out of sight and reach of children. Store in a temperature below 25°C. Do not use this medication after the expiry date stated on the carton and bottle. The expiry date refers to the last day of the month stated. Medications should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medications no longer required. This will help protect the environment.
The active substance of the medication is carbocisteine. 15 ml (1 measuring cup) of syrup contains 750 mg of carbocisteine. The other ingredients are: sucrose solution, methyl parahydroxybenzoate, caramel flavor, sodium hydroxide, purified water.
This medication is a yellow to light brown, transparent syrup with a caramel flavor and sweet taste. Packaging: a bottle containing 200 ml of syrup, in a cardboard box. A measuring cup with a capacity of 15 ml is included with the packaging.
PIERRE FABRE MEDICAMENT Les Cauquillous 81500 Lavaur France
Pierre Fabre Medicament Production Site Progipharm Rue du Lycée 45500 Gien France For more detailed information, please contact the local representative of the marketing authorization holder: Pierre Fabre Medicament Polska Sp. z o.o. ul. Belwederska 20/22 00-762 Warsaw Poland tel.: 22 559 63 00
{logo Pierre Fabre Medicament}
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.